At a Glance
| Phenylpiracetam | N-Methylbisfluoromodafinil | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 100–200 mg | 100–150 mg |
| Total Duration | 0.5–1 hrs | — |
| Routes | oral | oral |
Phenylpiracetam, a Stimulants, Nootropic, and N-Methylbisfluoromodafinil, a Stimulants, Nootropic, Eugeroics, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Phenylpiracetam is classified as a Stimulants, Nootropic while N-Methylbisfluoromodafinil is a Stimulants, Nootropic, Eugeroics, meaning they approach altered states through different pharmacological mechanisms. They share 8 documented effects in common, with 15 effects unique to Phenylpiracetam and 5 unique to N-Methylbisfluoromodafinil. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Phenylpiracetam | N-Methylbisfluoromodafinil | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 100–200 mg | 100–150 mg |
| Total Duration | 0.5–1 hrs | — |
| Routes | oral | oral |
| Effects | 23 documented | 13 documented |
| Interaction | Caution | |
| Level | Phenylpiracetam | N-Methylbisfluoromodafinil |
|---|---|---|
| Threshold | 50 mg | 25 mg |
| Light | 50–100 mg | 50–100 mg |
| Common | 100–200 mg | 100–150 mg |
| Strong | 200–400 mg | 150–200 mg |
| Heavy | 400 mg | 200 mg |
Phenylpiracetam
Total: 2 hrs – 3 hrs
N-Methylbisfluoromodafinil
Increased cardiovascular strain and neurotoxicity risk